We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Philip Morris Transformation Accelerates With IQOS and ZYN Growth
Read MoreHide Full Article
Key Takeaways
Philip Morris' smoke-free shipments rose 11.8%, driving 15.2% revenue growth in Q2 2025.
IQOS, ZYN and VEEV fueled smoke-free growth, lifting gross profit by 23.3% year over year.
Cigarette shipments fell 1.5% to 155.2B units, but still delivered $6B in quarterly revenues.
Philip Morris International Inc.’s (PM - Free Report) second-quarter 2025 results spotlight the central question for its long-term transformation: Can smoke-free momentum truly outweigh persistent declines in cigarettes? Smoke-free products, led by IQOS heated tobacco, ZYN nicotine pouches and VEEV e-vapor, surged 11.8% in shipment volumes, lifting net revenues by 15.2% and gross profit by 23.3% year over year. These gains pushed smoke-free to 41% of total revenues and 42% of gross profit.
By contrast, cigarette shipments fell 1.5% to 155.2 billion units, pressured by weakness in Turkey and Indonesia. Still, combustibles contribute $6 billion in quarterly revenues, a 2.1% increase year over year. Management expects full-year smoke-free volumes to grow 12-14%, while cigarette volumes drop about 2%.
Smoke-free growth has become the decisive lever for Philip Morris and the latest results show momentum remains firmly on track. IQOS is winning share in key markets, ZYN accelerated in the United States with 26% growth in the second quarter and VEEV shipments more than doubled. Importantly, smoke-free carries structurally higher margins, cushioning the profit impact of falling cigarettes.
The transition indicates a balance between legacy and emerging categories. Combustibles remain a major revenue and cash contributor, while smoke-free continues to expand its share of growth and profitability. The long-term outcome will depend on the extent to which smoke-free expansion balances declines in combustibles.
Philip Morris Competitor Snapshot
Altria Group, Inc. (MO - Free Report) is leaning heavily on its on! nicotine pouch brand to fuel smoke-free growth. In the second quarter of 2025, on! shipments climbed 26.5% year over year to 52.1 million cans. The brand now holds an 8.7% retail share of the U.S. oral tobacco category, and Altria continues to expand visibility through targeted retail campaigns and experiential marketing. Altria is investing to solidify on!’s role as its primary reduced-risk growth driver.
Turning Point Brands, Inc. (TPB - Free Report) is making an aggressive push into modern oral nicotine with its FRE and ALP pouch brands. In the second quarter of 2025, Modern Oral sales reached $30.1 million, up nearly eightfold year over year. Turning Point Brands raised its 2025 Modern Oral revenue target to $100-$110 million. To capture share in the growing smoke-free category, Turning Point Brands emphasized flavor innovation, brand visibility and expanded retail presence as core strategies.
PM’s Price Performance, Valuation & Estimates
Shares of Philip Morris have gained 6.1% in the past month compared with the industry’s growth of 11.3%.
Image Source: Zacks Investment Research
From a valuation standpoint, PM trades at a forward price-to-earnings ratio of 20.7X, up from the industry’s average of 15.69X.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for PM’s 2025 and 2026 earnings implies year-over-year growth of 14.2% and 11.9%, respectively.
Image: Bigstock
Philip Morris Transformation Accelerates With IQOS and ZYN Growth
Key Takeaways
Philip Morris International Inc.’s (PM - Free Report) second-quarter 2025 results spotlight the central question for its long-term transformation: Can smoke-free momentum truly outweigh persistent declines in cigarettes? Smoke-free products, led by IQOS heated tobacco, ZYN nicotine pouches and VEEV e-vapor, surged 11.8% in shipment volumes, lifting net revenues by 15.2% and gross profit by 23.3% year over year. These gains pushed smoke-free to 41% of total revenues and 42% of gross profit.
By contrast, cigarette shipments fell 1.5% to 155.2 billion units, pressured by weakness in Turkey and Indonesia. Still, combustibles contribute $6 billion in quarterly revenues, a 2.1% increase year over year. Management expects full-year smoke-free volumes to grow 12-14%, while cigarette volumes drop about 2%.
Smoke-free growth has become the decisive lever for Philip Morris and the latest results show momentum remains firmly on track. IQOS is winning share in key markets, ZYN accelerated in the United States with 26% growth in the second quarter and VEEV shipments more than doubled. Importantly, smoke-free carries structurally higher margins, cushioning the profit impact of falling cigarettes.
The transition indicates a balance between legacy and emerging categories. Combustibles remain a major revenue and cash contributor, while smoke-free continues to expand its share of growth and profitability. The long-term outcome will depend on the extent to which smoke-free expansion balances declines in combustibles.
Philip Morris Competitor Snapshot
Altria Group, Inc. (MO - Free Report) is leaning heavily on its on! nicotine pouch brand to fuel smoke-free growth. In the second quarter of 2025, on! shipments climbed 26.5% year over year to 52.1 million cans. The brand now holds an 8.7% retail share of the U.S. oral tobacco category, and Altria continues to expand visibility through targeted retail campaigns and experiential marketing. Altria is investing to solidify on!’s role as its primary reduced-risk growth driver.
Turning Point Brands, Inc. (TPB - Free Report) is making an aggressive push into modern oral nicotine with its FRE and ALP pouch brands. In the second quarter of 2025, Modern Oral sales reached $30.1 million, up nearly eightfold year over year. Turning Point Brands raised its 2025 Modern Oral revenue target to $100-$110 million. To capture share in the growing smoke-free category, Turning Point Brands emphasized flavor innovation, brand visibility and expanded retail presence as core strategies.
PM’s Price Performance, Valuation & Estimates
Shares of Philip Morris have gained 6.1% in the past month compared with the industry’s growth of 11.3%.
Image Source: Zacks Investment Research
From a valuation standpoint, PM trades at a forward price-to-earnings ratio of 20.7X, up from the industry’s average of 15.69X.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for PM’s 2025 and 2026 earnings implies year-over-year growth of 14.2% and 11.9%, respectively.
Image Source: Zacks Investment Research
Philip Morris currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.